Skip to Content

Magnesium Sulfate Injection

Last Updated: June 1, 2020
Status: Current

Products Affected - Description
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 2 mL vial, 25 count, NDC 63323-0064-03
    • Magnesium sulfate intravenous injection, Pfizer, 500 mg/mL, 10 mL syringe, 10 count, NDC 00409-1754-10
    • Magnesium sulfate intravenous injection, Pfizer, 500 mg/mL, 20 mL vial, 25 count, NDC 00409-2168-02
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 63323-0108-01
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 63323-0106-01
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 63323-0106-05
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 80 mg/mL, 50 mL premixed bag, 24 count, NDC 63323-0107-05
Reason for the Shortage
    • American Regent is not currently marketing magnesium sulfate which has been unavailable since late 2012.
    • Fresenius Kabi had magnesium sulfate injection on shortage due to increased demand for the product.
    • Pfizer has magnesium sulfate injection on shortage due to manufacturing delays.
    • X-Gen discontinued magnesium sulfate in April 2018.
    • Exela launched magnesium sulfate vials in May 2018.
    • WG Critical Care had magnesium sulfate injection on shortage due to increased demand for the product.
Available Products
    • Magnesium sulfate intravenous injection, Exela Pharma Sciences, 500 mg/mL, 10 mL vial, 25 count, NDC 51754-1000-04
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 10 mL vial, 25 count, NDC 63323-0064-11
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 20 mL vial, 25 count, NDC 63323-0642-20
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 500 mg/mL, 50 mL vial, 25 count, NDC 63323-0642-50
    • Magnesium sulfate intravenous injection, Pfizer, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 00409-6727-23
    • Magnesium sulfate intravenous injection, WG Critical Care, 10 mg/mL, 100 mL premixed bag, 24 count, NDC 44567-0410-24
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 1000 mL premixed bag, 24 count, NDC 63323-0106-10
    • Magnesium sulfate intravenous injection, Fresenius Kabi, 40 mg/mL, 500 mL premixed bag, 24 count, NDC 63323-0106-15
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 00409-6729-23
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 1000 mL premixed bag, 24 count, NDC 00409-6729-09
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 00409-6729-24
    • Magnesium sulfate intravenous injection, Pfizer, 40 mg/mL, 500 mL premixed bag, 24 count, NDC 00409-6729-03
    • Magnesium sulfate intravenous injection, Pfizer, 80 mg/mL, 50 mL premixed bag, 24 count, NDC 00409-6730-13
    • Magnesium sulfate intravenous injection, WG Critical Care, 40 mg/mL, 100 mL premixed bag, 24 count, NDC 44567-0421-24
    • Magnesium sulfate intravenous injection, WG Critical Care, 40 mg/mL, 50 mL premixed bag, 24 count, NDC 44567-0420-24

Estimated Resupply Dates

    • Fresenius Kabi has magnesium sulfate 40 mg/mL 50 mL and 100 mL premixed bags on back order and the company estimates a release date of early-June 2020 for the 50 mL bags and mid-June 2020 for the 100 mL bags. The 10 mg/mL 100 mL premixed bags are on back order and the company estimates a release date of early-June 2020. The 80 mg/mL 50 mL premixed bags are on back order and the company estimates a release date of mid-June 2020. The 500 mg/mL 2 mL vials are on back order and the company estimates a release date of early- to mid-June 2020. There are short-dated 500 mg/mL 2 mL vials and 50 mL vials with an expiration date of <9 months for the 2 mL vials and <8 months for the 50 mL vials.
    • Pfizer has magnesium sulfate 500 mg/mL 20 mL vials on back order and the company estimates a release date of June 2020. The 500 mg/mL 10 mL syringes are on back order and the company estimates a release date of June 2020.

Updated

Updated June 1, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 30, 2011 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide